| Patents for A61P 13 - Drugs for disorders of the urinary system (56,135) |
|---|
| 07/24/2001 | CA2221753C Use of flavanolignanes for the preparation of medicaments with antiproliferative activity in uterus, ovary and breast |
| 07/24/2001 | CA2042112C N'-alkyl-spiro-isoquinoline-pyrrolidine tetrones and analogs thereof useful as aldose reductase inhibitors |
| 07/24/2001 | CA2031588C Substituted cyclohexanols and cyclohexylamines as central nervous system agents |
| 07/19/2001 | WO2001051645A1 Obg3 globular head and uses thereof for decreasing body mass |
| 07/19/2001 | WO2001051638A2 Drug metabolizing enzymes |
| 07/19/2001 | WO2001051464A1 Novel vitamin d analogues |
| 07/19/2001 | WO2001051125A1 Inhibitors of prenyl-protein transferase |
| 07/19/2001 | WO2001051014A1 Pharmaceutical and cosmetic carrier or composition for topical application |
| 07/19/2001 | WO2001050873A1 Thickened oil compositions of edible oil |
| 07/19/2001 | WO2001005969A3 Electron transfer proteins |
| 07/19/2001 | WO2001005392A3 Method for treating chronic pain using mek inhibitors |
| 07/19/2001 | WO2001005383A3 Inhibition of renal uptake of radiomolecules with a combination of lysine and arginine |
| 07/19/2001 | WO2001004297A3 Human proteins having hydrophobic domains and dnas encoding these proteins |
| 07/19/2001 | WO2001004118A3 Quinuclidine derivatives and their use as muscarinic m3 receptor ligands |
| 07/19/2001 | WO2000076984A8 Novel compounds, their use and preparation |
| 07/19/2001 | WO2000073324A3 Modulation of gene expression in gastrointestinal inflammation |
| 07/19/2001 | WO2000071716A3 Vascular endothelial growth factor dimers |
| 07/19/2001 | WO2000055321B1 Vertebrate protein slit, dna sequence encoding it and uses thereof |
| 07/19/2001 | US20010008901 Nitrile derivatives that inhibit cathepsin K |
| 07/19/2001 | DE19961219A1 11beta-Phenylestratrien-Derivate mit Fluoralkylgruppen in der aromatischen Seitenkette, deren Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen 11beta-Phenylestratrien derivatives with fluoroalkyl groups in the aromatic side chain, their preparation and pharmaceutical compositions containing them |
| 07/19/2001 | DE10001879A1 New benzoylguanidine derivatives are Na+/H+ exchange inhibitors useful for the treatment and prevention of e.g. ischemic disorders, infarction, arrhythmia, angina pectoris and stroke |
| 07/19/2001 | CA2397340A1 Drug metabolizing enzymes |
| 07/19/2001 | CA2397081A1 Novel vitamin d analogues |
| 07/19/2001 | CA2397068A1 Pharmaceutical and cosmetic carrier or composition for topical application |
| 07/19/2001 | CA2396071A1 Thickened oil compositions of edible oil |
| 07/18/2001 | EP1115877A1 Polynucleotide constructs and uses thereof |
| 07/18/2001 | EP1115860A2 Membrane-associated organizational proteins |
| 07/18/2001 | EP1115847A1 Short peptides which selectively modulate the activity of protein kinases |
| 07/18/2001 | EP1115735A1 31 human secreted proteins |
| 07/18/2001 | EP1115720A2 Novel n-(iminomethyl)amine derivatives, their preparation, their use as medicines and compositions containing them |
| 07/18/2001 | EP1115712A1 Oxazole compounds as prostaglandin e2 agonists or antagonists |
| 07/18/2001 | EP1115708A1 Aminoalkyl-3,4-dihydroquinoline derivates as no-synthase inhibitors |
| 07/18/2001 | EP1115426A1 Method of diagnosing, monitoring, staging, imaging and treating gynecologic cancers and testicular cancer |
| 07/18/2001 | EP1115416A1 Use of substances with oxytocin activity in order to create cell regeneration |
| 07/18/2001 | EP1115391A1 Chemotherapy of cancer with acetyldinaline in combination with gemcitabine, capecitabine or cisplatin |
| 07/18/2001 | EP0674521B1 METHOD OF TREATMENT OF CHRONIC PROSTATITIS WITH 17$g(b)-N-TERTBUTYLCARBAMOYL-4-AZA-5$g(a)-ANDROST-1-EN-3-ONE |
| 07/18/2001 | CN1304453A Vaccine-induced hepatitis B viral strain and uses thereof |
| 07/18/2001 | CN1304408A N-benzodioxanylmethyl-piperidyl-methylamine compounds having effinity for 5-HT receptors |
| 07/18/2001 | CN1304318A Prostaglandin EP4 receptor agonist and treatment method |
| 07/18/2001 | CN1304311A Bridged indenopyrrolocarbazoles |
| 07/18/2001 | CN1304307A 4-benzyl piperidine alkylsulfoxide heterocycles and their use as subtype-selective NMDA receptor antagonists |
| 07/18/2001 | CN1068586C Crystalline polymorphic form of (S.S.S)-N-(1-[2-carboxy-3-(N2-mesyllysylamino)propyl]-1-cyclopenlylcarbonyl) throsine |
| 07/17/2001 | US6262267 Has gonadotropin-releasing hormone antagonizing activity; useful for preventing or treating sex hormone-dependent diseases, e,g., sex hormone-dependent cancers e.g., prostatic cancer, uterine cancer, breast cancer, pituitary tumor |
| 07/17/2001 | US6262257 Selective ion- and neutral molecule-binding agents forming supramolecular ensembles, and ion- and neutral molecule-separation agents |
| 07/17/2001 | US6262246 DNA encoding mammalian neuropeptides FF (NPFF) receptors and uses thereof |
| 07/17/2001 | US6262123 Ortho-substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament comprising them |
| 07/17/2001 | US6262118 Therapy of type 2 diabetes in a mammal by administering (-) 4-chlorophenyl-(3-trifluoromethylphenoxy)acetic acid derivative |
| 07/17/2001 | US6262102 Eprosartan monohydrate |
| 07/17/2001 | US6262046 Azetidinylpropylpiperidine derivatives, intermediates and use as tachykinin antagonists |
| 07/17/2001 | US6261588 Administering mushroom extract |
| 07/17/2001 | CA2130515C New 11-benzaldoxime-17.beta.-methoxy-17.alpha.-methoxymethylestradiene derivatives, methods for their production and pharmaceuticals containing these substances |
| 07/12/2001 | WO2001049838A2 Cis-acting regulatory nucleic acid sequences in the parathyroid hormone 3'-untranslated region |
| 07/12/2001 | WO2001049740A1 Novel fgf homolog zfgf12 |
| 07/12/2001 | WO2001049715A2 Methods and compositions for inhibiting neoplastic cell growth |
| 07/12/2001 | WO2001049711A2 Nucleic acids encoding (poly)peptides having chips activity |
| 07/12/2001 | WO2001049685A2 Sulfonamides and derivatives thereof that modulate the activity of endothelin |
| 07/12/2001 | WO2001049684A1 Novel tetrahydropyridines, preparation method and pharmaceutical compositions containing same |
| 07/12/2001 | WO2001049682A1 Condensed azepines as vasopressin agonists |
| 07/12/2001 | WO2001049673A2 Compounds and methods for modulation of estrogen receptors |
| 07/12/2001 | WO2001049661A1 5-THIA-φ-(SUBSTITUTED PHENYL)-PROSTAGLANDIN E ALCOHOLS, PROCESS FOR PREPARING THE ALCOHOLS AND PHARMACEUTICAL PREPARATIONS CONTAINING THE SAME AS THE ACTIVE INGREDIENT |
| 07/12/2001 | WO2001049654A2 Substituted aminomethyl-phenyl-cyclohexane derivatives |
| 07/12/2001 | WO2001049651A2 Aminomethyl-phenyl-cyclohexanone derivatives |
| 07/12/2001 | WO2001049309A2 Combinations of growth factors and i: upa or i: mmp for the treatment of damaged tissue |
| 07/12/2001 | WO2001049305A2 Process for obtaining thylakoids from plants, pure thylakoids and use thereof |
| 07/12/2001 | WO2001049303A1 Multivalent electron active compositions and methods of making and using same |
| 07/12/2001 | WO2001049302A1 Compositions and methods for facilitating skin growth and managing skin conditions |
| 07/12/2001 | WO2001049301A1 Methods of using electron active compounds for managing cancer |
| 07/12/2001 | WO2001049295A1 Use of low dosage bisphosphonates to inhibit cardiac and arterial calcification |
| 07/12/2001 | WO2001049294A1 Product for treating gynecomastia |
| 07/12/2001 | WO2001049288A1 Novel compounds and compositions as protease inhibitors |
| 07/12/2001 | WO2001049130A1 Canine health diet |
| 07/12/2001 | WO2000074724A3 Conjugates comprising cytokines and nucleic acids for treating proliferating cells |
| 07/12/2001 | WO2000005223A3 Heterocyclic derivatives and their use as integrin inhibitors |
| 07/12/2001 | WO2000000510A3 Growth factor modulators |
| 07/12/2001 | US20010007878 Mixture with a caloric density of about 2 calories/millileter of protein, fat, carbohydrates, vitamins and minerals, and arginine, which is essential to enhance the glomerular function of the kidneys |
| 07/12/2001 | US20010007873 Compounds such as 4-(6-amino-pyridin-2-yl)-3-methoxyphenol as nitric oxide synthase inhibitors used to treat central nervous system disorders, inflammatory disorders, septic shock, etc... |
| 07/12/2001 | DE19963179A1 Substituierte 1- und 2-Naphthol-Mannichbasen Substituted 1- and 2-naphthol Mannich bases |
| 07/12/2001 | DE19963174A1 Substituierte Pyrrol-Mannichbasen Substituted pyrrole Mannich bases |
| 07/12/2001 | DE10000312A1 Substituierte Aminomethyl-Phenyl-Cyclohexanderivate Substituted aminomethyl-phenyl-cyclohexane derivatives |
| 07/12/2001 | DE10000311A1 Aminomethyl-Phonyl-Cyclohexanonderivate Aminomethyl-Phonyl-cyclohexanone derivatives |
| 07/12/2001 | CA2396401A1 Novel fgf homolog zfgf12 |
| 07/12/2001 | CA2396393A1 Use of low dosage bisphosphonates to inhibit cardiac and arterial calcification |
| 07/12/2001 | CA2396310A1 Aminomethyl-phenyl-cyclohexanone derivatives |
| 07/12/2001 | CA2396304A1 Substituted aminomethyl-phenyl-cyclohexane derivatives |
| 07/12/2001 | CA2396257A1 Novel compounds and compositions as protease inhibitors |
| 07/12/2001 | CA2396059A1 Compounds and methods for modulation of estrogen receptors |
| 07/12/2001 | CA2395876A1 Nucleic acids encoding (poly)peptides having chips activity |
| 07/12/2001 | CA2395487A1 Composition for the treatment of damaged tissue |
| 07/12/2001 | CA2394721A1 Product for treating gynecomastia |
| 07/11/2001 | EP1114817A1 Substituted benzylamino piperidine compounds |
| 07/11/2001 | EP1114158A2 Human cytoskeleton associated proteins |
| 07/11/2001 | EP1114155A2 Human gpcr proteins |
| 07/11/2001 | EP1114149A1 Rnase p polypeptides |
| 07/11/2001 | EP1114146A2 Human serine/threonine protein kinases |
| 07/11/2001 | EP1114053A1 Pyrrolopyrimidines as protein kinase inhibitors |
| 07/11/2001 | EP1114051A1 INHIBITORS OF p38 |
| 07/11/2001 | EP1114048A1 Carboline derivatives as cgmp phosphodiesterase inhibitors |
| 07/11/2001 | EP1114037A1 Benzoxazine and benzothiazine derivatives and their use in medicines |
| 07/11/2001 | EP1114035A1 Quinazoline derivatives and pharmaceutical applications thereof |
| 07/11/2001 | EP1114029A1 Novel compounds |